Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Hansen Shannon MarieEVP & Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · derivative · entry 7 Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,060 Underlying: Common Stock · 1,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F7 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F8 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F8 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Hansen Shannon MarieEVP & Chief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · derivative · entry 6 Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,184 Underlying: Common Stock · 531 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Awarded on February 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 2/15/2023, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Hansen Shannon MarieEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 513 | $43.82 | $22,479.66 |
DisclosureSEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 4 Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,678 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Hansen Shannon MarieEVP & Chief Legal Officer
|
Exercise / conversionCommon Stock | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 3 Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,191 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Hansen Shannon MarieEVP & Chief Legal Officer
|
Tax withholdingCommon Stock | 190 | $43.82 | $8,325.80 |
DisclosureSEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 2 Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,754 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Hansen Shannon MarieEVP & Chief Legal Officer
|
Exercise / conversionCommon Stock | 531 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000192 · wk-form4_1724113906.xml · nonDerivative · entry 1 Hansen Shannon Marie · CIK 0001908267 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · derivative · entry 6 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,060 Underlying: Common Stock · 1,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F6 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F7 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F7 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 596 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · derivative · entry 5 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,787 Underlying: Common Stock · 596 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 25, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Carpenter RickChief Technology Officer
|
Tax withholdingCommon Stock | 513 | $43.82 | $22,479.66 |
DisclosureSEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 4 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,543 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionCommon Stock | 1,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 3 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Carpenter RickChief Technology Officer
|
Tax withholdingCommon Stock | 213 | $43.82 | $9,333.66 |
DisclosureSEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 2 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,619 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionCommon Stock | 596 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000191 · wk-form4_1724113896.xml · nonDerivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · derivative · entry 9 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,301 Underlying: Common Stock · 5,472 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F8 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F9 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F9 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · derivative · entry 8 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,709 Underlying: Common Stock · 2,236 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan, as amended. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · derivative · entry 7 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,377 Underlying: Common Stock · 793 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 2,774 | $43.82 | $121,556.68 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 6 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,766 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 5,472 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 5 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 1,134 | $43.82 | $49,691.88 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 4 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,068 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 2,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 402 | $43.82 | $17,615.64 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,966 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 793 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000190 · wk-form4_1724113886.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · derivative · entry 9 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,522 Underlying: Common Stock · 1,503 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · security: Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F8 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan. F9 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F9 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · derivative · entry 8 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,423 Underlying: Common Stock · 474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Awarded on May 25, 2022 pursuant to the 2013 Plan. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F6 · derivative.exercise_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F6 · derivative.expiration_date: RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2023, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · derivative · entry 7 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 487 Underlying: Common Stock · 163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 430 | $43.82 | $18,842.60 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 6 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,372 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 1,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 5 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 136 | $43.82 | $5,959.52 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 4 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,299 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 474 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 47 | $43.82 | $2,059.54 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,961 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| August 15, 2024 Filed Aug 20, 2024 00:31 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000188 · wk-form4_1724113864.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:52 UTC |
Allen DickDirector
|
GiftCommon Stock | 6,639 | $38.89 | $258,190.71 |
DisclosureSEC source: 0001438133-24-000180 · wk-form4_1723236714.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 22,757 F1 · kind: The shares were given as a bona fide gift. F2 · price: The price per share reflects the average of the high and low trading prices of Tandem Diabetes Care, Inc. (the Company) stock on the transaction date. F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:16 UTC |
Kyrillos Jean-ClaudeEVP & Chief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 43,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000170 · wk-form4_1721247403.xml · derivative · entry 1 Kyrillos Jean-Claude · CIK 0001804186 · EVP & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,634 Underlying: Common Stock · 43,634 shares Expires not disclosed F1 · security: Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F1 · derivative.exercise_price: Awarded on July 15, 2024 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan (the 2023 Plan). F2 · derivative.exercise_date: Restricted stock units (RSU) vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. F2 · derivative.expiration_date: Restricted stock units (RSU) vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 7/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000164 · wk-form4_1718916156.xml · derivative · entry 3 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,436 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Awarded on December 15, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. F4 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 12/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC |
Carpenter RickChief Technology Officer
|
Tax withholdingCommon Stock | 145 | $45.33 | $6,572.85 |
DisclosureSEC source: 0001438133-24-000164 · wk-form4_1718916156.xml · nonDerivative · entry 2 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,236 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC |
Carpenter RickChief Technology Officer
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000164 · wk-form4_1718916156.xml · nonDerivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC |
Cha MyoungilDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000163 · wk-form4_1718916130.xml · derivative · entry 2 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,749 Underlying: Common Stock · 1,749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:42 UTC |
Cha MyoungilDirector
|
Exercise / conversionCommon Stock | 1,749 | $45.33 | $79,282.17 |
DisclosureSEC source: 0001438133-24-000163 · wk-form4_1718916130.xml · nonDerivative · entry 1 Cha Myoungil · CIK 0001934068 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:41 UTC |
Malagueira Joao Paulo FalcaoDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000162 · wk-form4_1718916076.xml · derivative · entry 2 Malagueira Joao Paulo Falcao · CIK 0001937552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,749 Underlying: Common Stock · 1,749 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F3 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. F3 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan. Read SEC document |
| June 17, 2024 Filed Jun 20, 2024 20:41 UTC |
Malagueira Joao Paulo FalcaoDirector
|
Exercise / conversionCommon Stock | 1,749 | $45.33 | $79,282.17 |
DisclosureSEC source: 0001438133-24-000162 · wk-form4_1718916076.xml · nonDerivative · entry 1 Malagueira Joao Paulo Falcao · CIK 0001937552 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:10 UTC |
Allen DickDirector
|
OtherCommon Stock | 9,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000155 · wk-form4_1718309434.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 29,396 F1 · kind: The reported transaction was a transfer of shares from Mr. Allen's direct holdings to the Allen Family Trust dated October 12, 1981. F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| June 11, 2024 Filed Jun 13, 2024 20:10 UTC |
Allen DickDirector
|
OtherCommon Stock | 9,396 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000155 · wk-form4_1718309434.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · kind: The reported transaction was a transfer of shares from Mr. Allen's direct holdings to the Allen Family Trust dated October 12, 1981. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:39 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
OtherCommon Stock | 11,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000153 · wk-form4_1718228338.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 11,749 F1 · kind: The reported transaction was a transfer of shares from Elizabeth A. Gasser's direct holdings to The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee. F2 · ownership.nature: The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee. Read SEC document |
| June 10, 2024 Filed Jun 12, 2024 21:39 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
OtherCommon Stock | 11,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000153 · wk-form4_1718228338.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The reported transaction was a transfer of shares from Elizabeth A. Gasser's direct holdings to The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 22:40 UTC |
Allen DickDirector
|
GiftCommon Stock | 1,892 | $51.32 | $97,097.44 |
DisclosureSEC source: 0001438133-24-000150 · wk-form4_1718059204.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 20,000 F1 · kind: The shares were given as a bona fide gift to The Gammon Family Trust, dated April 18, 2000. F2 · price: The price per share reflects the average of the high and low trading prices of Tandem Diabetes Care, Inc. (the Company) stock on the transaction date. F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:22 UTC |
Allen DickDirector
|
SaleCommon Stock | 5,000 | $51.68 | $258,400.00 |
DisclosureSEC source: 0001438133-24-000148 · wk-form4_1717446134.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $51.62 to $51.70. F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| May 28, 2024 Filed May 28, 2024 18:44 UTC |
Leal JamesChief Manufacturing Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000142 · wk-form4_1716936284.xml · derivative · entry 4 Leal James · CIK 0001866570 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F6 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 28, 2024 Filed May 28, 2024 18:44 UTC |
Leal JamesChief Manufacturing Officer
|
Tax withholdingCommon Stock | 129 | $51.73 | $6,673.17 |
DisclosureSEC source: 0001438133-24-000142 · wk-form4_1716936284.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,876 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 28, 2024 Filed May 28, 2024 18:44 UTC |
Leal JamesChief Manufacturing Officer
|
Exercise / conversionCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000142 · wk-form4_1716936284.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · Chief Manufacturing Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2024 Filed May 28, 2024 22:44 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-24-000139 · wk-form4_1716936246.xml · derivative · entry 5 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Awarded on May 27, 2020 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan). F7 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F8 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F8 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 28, 2024 Filed May 28, 2024 22:44 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 134 | $51.73 | $6,931.82 |
DisclosureSEC source: 0001438133-24-000139 · wk-form4_1716936246.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,749 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.